Skip to content

Bio-Techne TECH Enterprise value

Enterprise value at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$222.48B+0.9%
Danaher logo
DanaherDHR
$148.16B-8.7%
Bruker logo
BrukerBRKR
$7.03B-14.9%
Revvity logo
RevvityRVTY
$12.88B-13.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$8B+4.2%
Agilent Technologies logo
Agilent TechnologiesA
$34.39B+5.1%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$9.07B-11.8%
P/E60.6×+13.6×
P/S7.5×-1.0×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Calculated from Bio-Techne’s reported figures.

The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Techne's enterprise value?
Bio-Techne (TECH) reported enterprise value of $8.26B in Q1 2026.
How has Bio-Techne's enterprise value changed year-over-year?
Bio-Techne's enterprise value decreased by 13.6% year-over-year, from $9.55B to $8.26B.
What is the long-term trend for Bio-Techne's enterprise value?
Over 4 years (2021 to 2025), Bio-Techne's enterprise value has grown at a -17.9% compound annual growth rate (CAGR), from $17.91B to $8.12B.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.